tiprankstipranks
Novartis AG (GB:0QLR)
LSE:0QLR
UK Market
0QLR
Novartis AG
RESEARCH TOOLSreports
Want to see GB:0QLR full AI Analyst Report?

Novartis AG (0QLR) Share Forecast & Price Target

12 Followers
See the Price Targets and Ratings of:

0QLR Analyst Ratings

Moderate Buy
14Ratings
Moderate Buy
6 Buy
6 Hold
2 Sell
Based on 14 analysts giving stock ratings to
Novartis
AG
in the past 3 months
TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers​ in the past 3 months

0QLR Stock 12 Month Forecast

Average Price Target

CHF121.83
▲(2.55% Upside)
Based on 14 Wall Street analysts offering 12 month price targets for Novartis AG in the last 3 months. The average price target is CHF121.83 with a high forecast of CHF140.00 and a low forecast of CHF95.00. The average price target represents a 2.55% change from the last price of CHF118.80.
{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"89":"CHF89","102":"CHF102","115":"CHF115","128":"CHF128","141":"CHF141"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":140,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">CHF140.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":121.83333333333333,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">CHF121.83</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":95,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">CHF95.00</span>\n  </div></div>","useHTML":true}}],"tickPositions":[89,102,115,128,141],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Aug<br/>2025","6":"Nov<br/>2025","9":"Feb<br/>2026","12":"May<br/>2026","25":"May<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,116,117.84615384615384,119.6923076923077,121.53846153846153,123.38461538461539,125.23076923076923,127.07692307692308,128.92307692307693,130.76923076923077,132.6153846153846,134.46153846153845,136.30769230769232,138.15384615384616,{"y":140,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,116,116.44871794871794,116.8974358974359,117.34615384615384,117.7948717948718,118.24358974358974,118.6923076923077,119.14102564102564,119.58974358974359,120.03846153846153,120.48717948717949,120.93589743589743,121.38461538461539,{"y":121.83333333333333,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,116,114.38461538461539,112.76923076923077,111.15384615384616,109.53846153846153,107.92307692307692,106.3076923076923,104.6923076923077,103.07692307692308,101.46153846153847,99.84615384615384,98.23076923076923,96.61538461538461,{"y":95,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":90.916,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.259,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":93.877,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 20, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":92.002,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 21, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":98.459,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 14,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 26, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":100.269,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 22, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 4</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":96.478,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 23, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":101.4,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 13, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 3</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":106.327,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 17,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":113.779,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 10, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 2</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":125.173,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 21,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 14, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":122.541,"date":1775001600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 22,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 15, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 6</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":116,"date":1777593600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 11, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 5</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}
Highest Price TargetCHF140.00Average Price TargetCHF121.83Lowest Price TargetCHF95.00
The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts​

Detailed List of Analyst Forecasts​
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on GB:0QLR
Sachin Jain
Bank of America Securities
Bank of America Securities
CHF140
Buy
17.85%
Upside
Reiterated
05/11/26
Sachin Jain Reiterates Buy on Improved Risk-Reward and Late-Stage Pipeline Strength, Keeps 140 CHF Price Target Unchanged
UBS Analyst forecast on GB:0QLR
Matthew Weston
UBS
UBS
CHF116
Hold
-2.36%
Downside
Reiterated
05/08/26
UBS Sticks to Its Hold Rating for Novartis AG (NOVN)
Kepler Capital Analyst forecast on GB:0QLR
David Evans
Kepler Capital
Kepler Capital
CHF135
Buy
13.64%
Upside
Reiterated
05/08/26
Kepler Capital Remains a Buy on Novartis AG (NOVN)
J.P. Morgan Analyst forecast on GB:0QLR
Richard Vosser
J.P. Morgan
J.P. Morgan
CHF135
Buy
13.64%
Upside
Reiterated
05/05/26
J.P. Morgan Remains a Buy on Novartis AG (NOVN)
Bernstein Analyst forecast on GB:0QLR
Justin Smith
Bernstein
Bernstein
CHF125
Hold
5.22%
Upside
Assigned
04/29/26
Bernstein Sticks to Their Hold Rating for Novartis AG (NOVN)
Deutsche Bank Analyst forecast on GB:0QLR
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
CHF135
Buy
13.64%
Upside
Reiterated
04/29/26
Deutsche Bank Sticks to Their Buy Rating for Novartis AG (NOVN)
Goldman Sachs Analyst forecast on GB:0QLR
James Quigley
Goldman Sachs
Goldman Sachs
CHF105→CHF106
Sell
-10.77%
Downside
Reiterated
04/29/26
Goldman Sachs Sticks to Its Sell Rating for Novartis AG (NOVN)
DZ BANK AG Analyst forecast on GB:0QLR
Elmar Kraus
DZ BANK AG
DZ BANK AG
―
Hold
―
Reiterated
04/28/26
Novartis AG (NOVN) Gets a Hold from DZ BANK AG
Barclays Analyst forecast on GB:0QLR
James Gordon CFA
Barclays
Barclays
CHF120
Hold
1.01%
Upside
Reiterated
04/28/26
Barclays Remains a Hold on Novartis AG (NOVN)
Morgan Stanley Analyst forecast on GB:0QLR
Thibault Boutherin
Morgan Stanley
Morgan Stanley
CHF135
Buy
13.64%
Upside
Reiterated
04/28/26
Novartis: Buy Rating Reaffirmed as Growth Drivers and Pipeline Offset Soft Q1, $135 Price Target Maintained
Jefferies Analyst forecast on GB:0QLR
James Vane
Jefferies
Jefferies
CHF110
Hold
-7.41%
Downside
Reiterated
04/28/26
Novartis AG (NOVN) Gets a Hold from Jefferies
Citi Analyst forecast on GB:0QLR
Graham Parry
Citi
Citi
―
Buy
―
Reiterated
04/13/26
Citi Reaffirms Their Buy Rating on Novartis AG (NOVN)
HSBC Analyst forecast on GB:0QLR
Rajesh Kumar
HSBC
HSBC
CHF89→CHF95
Sell
-20.03%
Downside
Reiterated
03/17/26
Novartis price target raised to CHF 95 from CHF 89 at HSBCNovartis price target raised to CHF 95 from CHF 89 at HSBC
Berenberg Bank Analyst forecast on GB:0QLR
Luisa Hector
Berenberg Bank
Berenberg Bank
CHF92→CHF110
Hold
-7.41%
Downside
Assigned
03/06/26
Berenberg Bank Reaffirms Their Hold Rating on Novartis AG (NOVN)
Erste Group Analyst forecast on GB:0QLR
Stephan Lingnau
Erste Group
Erste Group
―
Buy
―
Reiterated
01/23/26
Erste Group Sticks to Their Buy Rating for Novartis AG (NOVN)
Analyst Type
Any
Any
Human Analysts
Ranks
Any
Any
Analyst Rating
Any
Any
Upside/ Downside
Any
Any
Action
Any
Any
Analyst Profile
Expert Firm
Price Target
Position
Upside / Downside
Action
Date
Follow
Article
Bank of America Securities Analyst forecast on GB:0QLR
Sachin Jain
Bank of America Securities
Bank of America Securities
CHF140
Buy
17.85%
Upside
Reiterated
05/11/26
Sachin Jain Reiterates Buy on Improved Risk-Reward and Late-Stage Pipeline Strength, Keeps 140 CHF Price Target Unchanged
UBS Analyst forecast on GB:0QLR
Matthew Weston
UBS
UBS
CHF116
Hold
-2.36%
Downside
Reiterated
05/08/26
UBS Sticks to Its Hold Rating for Novartis AG (NOVN)
Kepler Capital Analyst forecast on GB:0QLR
David Evans
Kepler Capital
Kepler Capital
CHF135
Buy
13.64%
Upside
Reiterated
05/08/26
Kepler Capital Remains a Buy on Novartis AG (NOVN)
J.P. Morgan Analyst forecast on GB:0QLR
Richard Vosser
J.P. Morgan
J.P. Morgan
CHF135
Buy
13.64%
Upside
Reiterated
05/05/26
J.P. Morgan Remains a Buy on Novartis AG (NOVN)
Bernstein Analyst forecast on GB:0QLR
Justin Smith
Bernstein
Bernstein
CHF125
Hold
5.22%
Upside
Assigned
04/29/26
Bernstein Sticks to Their Hold Rating for Novartis AG (NOVN)
Deutsche Bank Analyst forecast on GB:0QLR
Emmanuel Papadakis
Deutsche Bank
Deutsche Bank
CHF135
Buy
13.64%
Upside
Reiterated
04/29/26
Deutsche Bank Sticks to Their Buy Rating for Novartis AG (NOVN)
Goldman Sachs Analyst forecast on GB:0QLR
James Quigley
Goldman Sachs
Goldman Sachs
CHF105→CHF106
Sell
-10.77%
Downside
Reiterated
04/29/26
Goldman Sachs Sticks to Its Sell Rating for Novartis AG (NOVN)
DZ BANK AG Analyst forecast on GB:0QLR
Elmar Kraus
DZ BANK AG
DZ BANK AG
―
Hold
―
Reiterated
04/28/26
Novartis AG (NOVN) Gets a Hold from DZ BANK AG
Barclays Analyst forecast on GB:0QLR
James Gordon CFA
Barclays
Barclays
CHF120
Hold
1.01%
Upside
Reiterated
04/28/26
Barclays Remains a Hold on Novartis AG (NOVN)
Morgan Stanley Analyst forecast on GB:0QLR
Thibault Boutherin
Morgan Stanley
Morgan Stanley
CHF135
Buy
13.64%
Upside
Reiterated
04/28/26
Novartis: Buy Rating Reaffirmed as Growth Drivers and Pipeline Offset Soft Q1, $135 Price Target Maintained
Jefferies Analyst forecast on GB:0QLR
James Vane
Jefferies
Jefferies
CHF110
Hold
-7.41%
Downside
Reiterated
04/28/26
Novartis AG (NOVN) Gets a Hold from Jefferies
Citi Analyst forecast on GB:0QLR
Graham Parry
Citi
Citi
―
Buy
―
Reiterated
04/13/26
Citi Reaffirms Their Buy Rating on Novartis AG (NOVN)
HSBC Analyst forecast on GB:0QLR
Rajesh Kumar
HSBC
HSBC
CHF89→CHF95
Sell
-20.03%
Downside
Reiterated
03/17/26
Novartis price target raised to CHF 95 from CHF 89 at HSBCNovartis price target raised to CHF 95 from CHF 89 at HSBC
Berenberg Bank Analyst forecast on GB:0QLR
Luisa Hector
Berenberg Bank
Berenberg Bank
CHF92→CHF110
Hold
-7.41%
Downside
Assigned
03/06/26
Berenberg Bank Reaffirms Their Hold Rating on Novartis AG (NOVN)
Erste Group Analyst forecast on GB:0QLR
Stephan Lingnau
Erste Group
Erste Group
―
Buy
―
Reiterated
01/23/26
Erste Group Sticks to Their Buy Rating for Novartis AG (NOVN)
Stocks with the Highest Top Analyst Consensus in the General Sector
xxx
xxx
xxx
xxx
xxx
Find stocks in the General sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Novartis AG

3 Months
xxx
Success Rate
21/31 ratings generated profit
68%
Average Return
+3.36%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 3 Months would result in 67.74% of your transactions generating a profit, with an average return of +3.36% per trade.
1 Year
David EvansKepler Capital
Success Rate
28/31 ratings generated profit
90%
Average Return
+12.88%
Copying David Evans's trades and holding each position for 1 Year would result in 90.32% of your transactions generating a profit, with an average return of +12.88% per trade.
2 Years
xxx
Success Rate
28/31 ratings generated profit
90%
Average Return
+22.80%
Copying xxxxxxxxxxxxxxxxxx
 trades and holding each position for 2 Years would result in 90.32% of your transactions generating a profit, with an average return of +22.80% per trade.
The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

0QLR Analyst Recommendation Trends

Rating
Jan 26
Feb 26
Mar 26
Apr 26
May 26
Strong Buy
0
0
0
0
0
Buy
17
19
21
22
18
Hold
11
10
14
15
11
Sell
2
2
6
6
5
Strong Sell
0
0
0
0
0
total
30
31
41
43
34
In the current month, 0QLR has received 18 Buy Ratings, 11 Hold Ratings, and 5 Sell Ratings. 0QLR average Analyst price target in the past 3 months is 121.83.
Each month's total comprises the sum of three months' worth of ratings.

0QLR Financial Forecast

0QLR Earnings Forecast

Next quarter’s earnings estimate for 0QLR is CHF1.70 with a range of CHF1.63 to CHF1.81. The previous quarter’s EPS was CHF1.55. 0QLR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year 0QLR has Performed in-line its overall industry.
Next quarter’s earnings estimate for 0QLR is CHF1.70 with a range of CHF1.63 to CHF1.81. The previous quarter’s EPS was CHF1.55. 0QLR beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 57.89% of the time in the same period. In the last calendar year 0QLR has Performed in-line its overall industry.

0QLR Sales Forecast

Next quarter’s sales forecast for 0QLR is CHF11.04B with a range of CHF10.65B to CHF11.33B. The previous quarter’s sales results were CHF10.28B. 0QLR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year 0QLR has Performed in-line its overall industry.
Next quarter’s sales forecast for 0QLR is CHF11.04B with a range of CHF10.65B to CHF11.33B. The previous quarter’s sales results were CHF10.28B. 0QLR beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 53.24% of the time in the same period. In the last calendar year 0QLR has Performed in-line its overall industry.

0QLR Stock Forecast FAQ

What is GB:0QLR’s average 12-month price target, according to analysts?
Based on analyst ratings, Novartis AG’s 12-month average price target is 121.83.
    What is GB:0QLR’s upside potential, based on the analysts’ average price target?
    Novartis AG has 2.55% upside potential, based on the analysts’ average price target.
      Can I see which stocks the top-ranking analysts are rating?
      Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
        How can I follow the stock ratings of top Wall Street analysts?
        Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
          Is Novartis AG a Buy, Sell or Hold?
          Novartis AG has a consensus rating of Moderate Buy, which is based on 6 buy ratings, 6 hold ratings and 2 sell ratings.
            What is Novartis AG’s share price target?
            The average share price target for Novartis AG is 121.83. This is based on 14 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
            The highest analyst share price target is CHF140.00 ,and the lowest forecast is CHF95.00. The average share price target represents 2.55% Increase from the current price of CHF118.8.
              What do analysts say about Novartis AG?
              Novartis AG’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 14 Wall Streets Analysts.
                How can I buy shares of Novartis AG?
                To buy shares of GB:0QLR, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.